Breast screening saves lives but raises overtreatment

Screening for breast cancer saves over 1,000 lives a year but will cause unnecessary harm to thousands more, an independent review has found.

Mammography exammination (Photo: SPL)
Mammography exammination (Photo: SPL)

An independent panel of experts who reviewed the evidence said women screened for breast cancer were 20% less likely to die of the disease.

The review found 1,300 lives are saved each year through the NHS Breast Screening programme, but a further 4,000 women will have tumours diagnosed which would not have caused illness. Overdiagnosis can lead to unnecessary harm from treatments including chemotherapy and radiotherapy.

Professor Michael Marmot of University College London, who led the panel, said women needed help when weighing up the benefits and potential harms of screening. 'Clear communication of these harms and benefits to women is essential, and the core of how a modern health system should function,' he said.

Professor Sir Mike Richards, national cancer director, said: 'I welcome the fact that the review clearly recommends that breast screening should continue.

'But the key thing is that we communicate this new information to women so they can make an informed choice for themselves. NHS Cancer Screening Programmes have already asked independent academics to develop new materials to give the facts in a clear, unbiased way. I hope to see them in use in the next few months.'

He added: 'If any woman has concerns about breast screening she should talk to her GP or health professional.'

The NHS Breast Screening programme invites all women aged over 50 every three years.

A review of the benefits and harms from screening was commissioned by the DH and Cancer Research UK in October 2011.

It followed an open letter from Professor Susan Bewley, a consultant obstetrician at King’s College London, who said NHS leaflets had ‘exaggerated benefits and did not spell out the risk’ of screening.

She said: ‘The oft repeated statement that "1,400 lives a year are saved" has not been subjected to proper scrutiny.’

In response, Professor Mike Richards, England’s national cancer director, said a review would  resolve ‘ongoing controversy’ over the programme.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...